WHO & @FIFAcom are teaming up for the #SafeHome campaign to raise awareness about domestic violence & support those at risk, during the #16Days of Activism against Gender-Based Violence.

πŸ‘‰ bit.ly/3CSmcSY
Across their lifetime, 1⃣ in 3⃣ πŸ™Žβ€β™€οΈ aged 15 & over, ~736 million, are subjected to physical &/or sexual violence by an intimate partner or sexual violence from a non-partner - a number that has remained largely unchanged over the past decade.

#SafeHome

πŸ‘‰bit.ly/3CSmcSY
If you are experiencing violence & need to leave in a hurry:
🏘️ Identify a friend, neighbour, relative or #SafeHome you can go to
πŸ”€ Plan how to get there
πŸŽ’ Keep ready essential personal items to take with you

#16Days
If you are worried, remember you can:
βœ… Reach out to supportive family, friends or neighbours
πŸ†˜ Use a safe code word in the case of an emergency
πŸ“ž Call a hotline or access information online if possible

#SafeHome

1⃣ in 4⃣ young women (aged 15-24 years) who have been in a relationship will have already experienced violence by an intimate partner by the time they reach their mid-twenties.

Everyone deserves a #SafeHome!

πŸ‘‰ bit.ly/3CSmcSY

#16Days

β€’ β€’ β€’

Missing some Tweet in this thread? You can try to force a refresh
γ€€

Keep Current with World Health Organization (WHO)

World Health Organization (WHO) Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @WHO

26 Nov
The Technical Advisory Group on SARS-CoV-2 Virus Evolution met today to review what is known about the #COVID19 variant B.1.1.529.
They advised WHO that it should be designated a Variant of Concern.
WHO has named it Omicron, in line with naming protocols bit.ly/3r8YrEd
The designation of Variant of Concern means:
πŸ”΄ countries should share genome sequences
πŸ”΄ report initial cases/clusters to WHO
πŸ”΄ perform field investigations & lab assessments to understand impacts, epidemiology, severity, effectiveness of public health & social measures
This new #COVID19 Variant of Concern Omicron underscores the need to accelerate #VaccinEquity and get COVID-19Β vaccines to health workers, older people and others at risk who still have not received their first and second doses.

#InThisTogether Image
Read 4 tweets
25 Nov
πŸ†• Interim statement on #COVID19 vaccination for children & adolescents bit.ly/32jwBur
Countries should consider the individual & population benefits of immunising children and adolescents in their specific epidemiological and social context when developing their #COVID19 immunisation policies and programs bit.ly/32jwBur
As children & adolescents tend to have milder disease compared to adults, unless they are in a group at higher risk of severe #COVID19, it is less urgent to vaccinate them than older people, those with chronic health conditions & health workers bit.ly/32jwBur
Read 6 tweets
24 Nov
@DrTedros "Last week, more than 60% of all reported cases and deaths from #COVID19 globally were once again in Europe. The sheer number of cases is translating to unsustainable pressure on health systems and exhausted #healthworkers"-@DrTedros
@DrTedros "In many countries and communities, we are concerned about a false sense of security that vaccines have ended the #COVID19 pandemic, and that people who are vaccinated do not need to take any other precautions"-@DrTedros
Read 28 tweets
23 Nov
WHO & @MedsPatentPool announce the first transparent, global, non-exclusive licence for a #COVID19 technology, after finalizing a licensing agreement with @CSIC for a COVID-19 serological antibody technology.

πŸ‘‰ bit.ly/3nJQMtL
The test effectively checks for the presence of anti-SARS-CoV-2 antibodies developed either in response to an infection or to a vaccine. This represents the first test licence signed by @MedsPatentPool & included in WHO’s #COVID19 Technology Access Pool

πŸ‘‰bit.ly/3nJQMtL
The aim of the licence is to facilitate the rapid manufacture and commercialization of @CSIC’s #COVID19 serological test worldwide. The agreement covers all related patents and the biological material necessary for manufacture of the test.

πŸ‘‰bit.ly/3nJQMtL
Read 6 tweets
23 Nov
πŸ†• Updated guidelines on the management of multisystem inflammatory syndrome in children associated with #COVID19 bit.ly/3l0vZQW Image
The updated guidelines recommend the use of corticosteroids in hospitalized children (aged 0-18 years) with this condition, in addition to supportive treatment and care bit.ly/3l0vZQW
Multisystem inflammatory syndrome is a rare but serious condition where children with #COVID19 develop inflammation affecting different organs of the body bit.ly/3l0vZQW
Read 4 tweets
21 Nov
Today is the World Day of Remembrance for Road Traffic Victims.

Every 24 seconds, the 🌍 loses:
a child
a father
a mother
a brother
a sister
a friend
a colleague...

Remember those who died.
Support those who survived.
Take action to save lives.
Every year the lives of nearly 1.3 million people 🌍 are cut short because of road traffic crashes 🚦

Today and every day, let's take a moment to remember them.
bit.ly/3HuLScd

#RoadSafety Image
Those rebuilding their lives after road traffic crashes and their families deserve appropriate medical, psychological, legal, and financial support.
bit.ly/3HuLScd

#Roadsafety Image
Read 5 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Thank you for your support!

Follow Us on Twitter!

:(